Our site uses cookies to provide you with the best possible user experience, if you choose to continue then we will assume that you are happy for your web browser to receive all cookies from our website. If you would like more information, please visit our cookie policy page.

The following are the requirements for the medical certification of aircrew, including guidance material issued by the UK CAA Medical Department in relation to Infectious diseases.

Implementing Rules

Acceptable Means of Compliance

Guidance Material

MED.B.040 Infectious Disease

(a) Applicants shall have no established medical history or clinical diagnosis of any infectious disease which is likely to interfere with the safe exercise of the privileges of the applicable licence held.

Class 1

(a) Infectious disease - General In cases of infectious disease, consideration should be given to a history of, or clinical signs indicating, underlying impairment of the immune system.

Class 1
(b) Tuberculosis
Applicants with active tuberculosis should be assessed as unfit. A fit assessment may be considered following completion of therapy.

Class 2
(a) Tuberculosis
Applicants with active tuberculosis should be assessed as unfit until completion of therapy.

Class 1
(c) Syphilis
Acute syphilis is disqualifying. A fit assessment may be considered in the case of those fully treated and recovered from the primary and secondary stages.

Infectious hepatitis

(b) Applicants who are HIV positive may be assessed as fit subject to satisfactory aeromedical evaluation. Applicants for a class 1 medical certificate shall be referred to the licensing authority.

Class 1
(d) HIV infection
(1) HIV positivity is disqualifying. A fit assessment with a multi-pilot limitation may be considered for individuals with stable, non-progressive disease. Frequent review is required.
(2) The occurrence of AIDS or AIDS related complex is disqualifying.

HIV infection

Class 2
(b) HIV infection
A fit assessment may be considered for HIV positive individuals with stable, non-progressive disease if full investigation provides no evidence of HIV-associated diseases that might give rise to incapacitating symptoms.